Clinical Trial Update: Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating long-term safety, tolerability, and efficacy of Alpha-1 Antitrypsin (AAT) in Type 1 diabetes mellitus, focusing on beta cell preservati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Alpha-1 Antitrypsin (alpha-1 antitrypsin)

Snippet

Sponsor: Rabin Medical Center | Conditions: Type 1 Diabetes, Beta Cell Preservation | Phase 2 | Status: COMPLETED